Breakthrough T1D Announces New Funding Opportunity
We are pleased to announce that Breakthrough T1D is soliciting Expressions of Interest (EOI) for the study of modifications of beta cell antigens in the immunopathogenesis and treatment of type 1 diabetes. Below please find more information on this funding opportunity:
Please note the following deadlines:
Expression of Interest: September 9, 2011
Application Due Date: December 2, 2011
Please visit the Requests for Application section of the Breakthrough T1D website for more information. And please be sure to visit the Breakthrough T1D website periodically for application deadline/guideline updates.